Issue: Volume XII No. 11 - August 1, 2005

New Federal Anti-kickback Investigation

POTENTIAL ANTI-KICKBACK VIOLATIONS in ancillary clinical service arrangements between referring physicians and providers like radiologists and laboratories continue to attract the interest of federal healthcare investigators. Right now, it appears radiology is a primary target. Last week, the Wall Street Journal disclosed that federal health investigators issued warrants and subpoenas to University MRI & Diagnostic …

New Federal Anti-kickback Investigation Read More »

For Quest and LabCorp, The Story is “Molecular”

CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecular technologies. The latest such deal is Quest Diagnostics’ $42.8 million agreement with Ciphergen Biosystems. …

For Quest and LabCorp, The Story is “Molecular” Read More »

Technology Can Now Enable “Card Swipe” for Draw Sites

COLLECTING SMALL AMOUNTS of money from patients for deductible, co-pay, and self-pay fees has always bedeviled laboratories. However, new technology holds the promise of solving this long-standing problem. BlueCross BlueShield of South Carolina (BCBC-SC) is currently offering a new “card-swipe” device to physicians in the state. The device lets insured beneficiaries see exactly how much …

Technology Can Now Enable “Card Swipe” for Draw Sites Read More »

Pinkus DermPath Earns ISO-9000 Certification

CEO SUMMARY: After learning about quality management systems at a recent Executive War College, the lab director at Pinkus Dermatopathology recognized how such techniques could be used in his lab to improve quality, reduce errors, and create a better working environment for both pathologists and lab staff. ISO-9000 was the quality system of choice because …

Pinkus DermPath Earns ISO-9000 Certification Read More »

Molecular Diagnostics: How Beaumont Built A Successful Program

CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key junctures, and careful evaluation of the finances for each molecular assay added to the …

Molecular Diagnostics: How Beaumont Built A Successful Program Read More »

“August 1, 2005 Intelligence: Late Breaking Lab News”

Redwood City, California-based Genomic Health, Inc. is considering an initial public offering (IPO) to raise as much as $75 million. The company filed preliminary documents with the Securities and Exchange Commission (SEC) on July 15, 2005. In January 2004, Genomic Health launched OncoType D™ for early-stage breast cancer patients. The company is assembling clinical data …

“August 1, 2005 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.